How to Buy Cardiol Therapeutics Stock
Cardiol Therapeutics Inc
Cardiol Therapeutics Inc. , a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD).
Cardiol Therapeutics stock last closed at $0.67, up 0.15% from the previous day, and has decreased 48.22% in one year. It has underperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.15 percentage points. Cardiol Therapeutics stock is currently +48.44% from its 52-week low of $0.45, and -60.71% from its 52-week high of $1.70.
There are currently 64.1M shares of CRDL outstanding. The market value of CRDL is $42.82M. In the past 24 hours, 77,854 CRDL shares were traded.
How to Buy Cardiol Therapeutics Stock
Not sure how to invest in Cardiol Therapeutics stock? Here's how.
- Decide where to buy Cardiol Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've analyzed dozens of stock brokerages and apps to help you choose where to buy Cardiol Therapeutics stock.
- Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Deposit funds into your brokerage account: Select your payment method and add your details.
- Analyze Cardiol Therapeutics stock: The Cardiol Therapeutics ticker symbol is CRDL. Is Cardiol Therapeutics stock a good investment? Should you buy shares of CRDL? How do CRDL's underlying business fundamentals look? Do top analysts think Cardiol Therapeutics is a good buy? Why has CRDL's stock price moved recently? (Hint: Our stock market analysis website can help you evaluate if CRDL is a good stock to buy).
- Execute your CRDL purchase: Decide if you will purchase CRDL shares at the current market price or use a limit order to buy CRDL shares at a given price.
- Get key alerts regarding your CRDL investment: Create a watchlist to important notifications about your position in Cardiol Therapeutics stock.
Step 1: Decide where to buy Cardiol Therapeutics stock
You will need a brokerage account to access the NASDAQ market and buy CRDL stock.
Our favorite brokerage: eToro
In our opinion, eToro is the best place to buy stocks. eToro gives you:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to world markets: From Tech to Industrials, New York to Tokyo — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro has a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by signing up for an account with eToro today.
Open eToro AccountStep 2: Create your brokerage account
Now that you've chosen the best brokerage, the next step is to fill out some personal details so you can invest in CRDL stock today.
How to Start a New Account on eToro
- Click here to get started.
- Enter your personal details to start a new trading account.
- Send your info by clicking the "Create Account" button.
Step 3: Deposit funds into your brokerage account
Now that you have filled out your info on a mobile trading app, you need to deposit funds:
Check out this video walkthrough to see the process of transferring funds into your new investment account.
Step 4: Analyze Cardiol Therapeutics stock
After you have identified the best place to buy Cardiol Therapeutics stock, it's crucial to research their stock prior to buying, so you truly understand the risk as well as the opportunity.
Cardiol Therapeutics Numbers
CRDL Fundamentals
WallStreetZen was designed to help part-time investors do more in-depth fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on CRDL's stock page.
Is CRDL stock properly valued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge CRDL's intrinsic value.
Using relative valuations methods:
- CRDL may be undervalued based on its P/B ratio of 1.28x, relative to Drug Manufacturers - Specialty & Generic industry P/B ratio of 1.79x
You can access more valuation analysis on CRDL's stock here.
CRDL Financial Health Summary
Pros:
- There are more short-term assets than short-term liabilities on the CRDL balance sheet.
- CRDL has cash burn of 20767458. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the CRDL balance sheet.
- CRDL has a low debt to equity ratio of 0.16.
- CRDL has $36.37M in cash and short term investments. This is enough to cover its annual cash burn of $20.77M.
Is it a good time to buy CRDL stock, according to analysts?
Out of 1 sell side analysts who research CRDL, the consensus analyst rating on Cardiol Therapeutics is a Strong Buy
It's important to note that analyst forecasts are not recommendations, nor are they financial advice.
Most Recent CRDL Analyst Forecasts
Edward Nash, a top 24% analyst from Canaccord Genuity maintains CRDL with a strong buy rating and raises their CRDL price target from $5.00 to $6.00, on May 19, 2023.
Maintaining his Strong Buy rating, Nash raised his price target on Cardiol Therapeutics Inc. by 20%.
Management thinks that cash-on-hand will be sufficient to achieve "corporate milestones and support operations into Q2 2026," the analyst told investors.
However, "the shortening of the discount period in" his model is the main reason for his PT update, Nash noted.
You can dig deeper into what analysts are saying on the Cardiol Therapeutics stock forecast page.
CRDL Technical Indicators
CRDL Performance Numbers
Last year, CRDL revenue was $0.00. In the past one years, CRDL's revenue has grown by -100% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 15.35%.
You can research CRDL's earnings and revenue performance here.
What are CRDL executives and large shareholders up to?
Over the past year, executives and large shareholders at CRDL have not bought or sold any shares.
Get more info about who owns CRDL shares here.
Does CRDL provide a stable income stream?
No, Cardiol Therapeutics doesn't provide an income stream by paying out dividends.
CRDL Social Trading Data
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Execute your CRDL purchase
You have two main options:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are generally the easiest way to buy. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a specific price, use a limit order.
Hit the Open Trade button and your broker will place your order.
If you want more help investing in stocks on eToro, click the how to video below:
Step 6: Get key alerts regarding your CRDL investment
Now that you own some shares in CRDL, you'll want to stay up-to-date on your company.
Make a watchlist to get notified of important updates regarding your CRDL stock.
CRDL Feed
How to Buy Stock in Cardiol Therapeutics
To summarize, here are the 6 steps for buying Cardiol Therapeutics stock:
- Decide where to buy Cardiol Therapeutics stock
- Create your brokerage account
- Deposit funds into your brokerage account
- Analyze Cardiol Therapeutics stock
- Execute your CRDL purchase
- Get key alerts regarding your CRDL investment
If you are looking for a place to buy stocks, eToro is our recommended option.
Get Started with eToro TodayIf you would like to get the latest scoop on your new investment in Cardiol Therapeutics, add CRDL to your watchlist by clicking the button below.
More Articles You May Like
FAQ
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.